Towa Pharmaceutical Co., Ltd. (4553) Press Release
Consolidated Financial Results for the Three Months Ended June 30, 2026 (Based on Japanese GAAP)
Earlier from Towa Pharmaceutical
- Notice of Completion of Payment for the Issuance of 1st Series Class A Preferred Shares through Third-Party Allotment
- Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
- Notice of Acquisition of Shares of Tanabe Pharma Factory Co., Ltd. and Transfer of Manufacturing and Marketing Approvals
- Notice of Changes in Officers